Scientific paper - Original scientific paper
Lipofilnost salicilamida
Acta Pharmaceutica, 54 (2004), 2; 91-101. urn:nbn:hr:163:408547


Cite this document

Medić Šarić, M., Mornar, A. & Jasprica, I. (2004). Lipofilnost salicilamida. Acta Pharmaceutica, 54. (2), 91-101. Retrieved from https://urn.nsk.hr/urn:nbn:hr:163:408547

Medić Šarić, Marica, et al. "Lipofilnost salicilamida." Acta Pharmaceutica, vol. 54, no. 2, 2004, pp. 91-101. https://urn.nsk.hr/urn:nbn:hr:163:408547

Medić Šarić, Marica, Ana Mornar and Ivona Jasprica. "Lipofilnost salicilamida." Acta Pharmaceutica 54, no. 2 (2004): 91-101. https://urn.nsk.hr/urn:nbn:hr:163:408547

Medić Šarić, M., Mornar, A. and Jasprica, I. (2004) 'Lipofilnost salicilamida', Acta Pharmaceutica, 54(2), pp. 91-101. Available at: https://urn.nsk.hr/urn:nbn:hr:163:408547 (Accessed 02 December 2022)

Medić Šarić M, Mornar A, Jasprica I. Lipofilnost salicilamida. Acta Pharmaceutica [Internet]. 2004 [cited 2022 December 02];54(2):91-101. Available at: https://urn.nsk.hr/urn:nbn:hr:163:408547

M. Medić Šarić, A. Mornar and I. Jasprica, "Lipofilnost salicilamida", Acta Pharmaceutica, vol. 54, no. 2, pp. 91-101, 2004. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:163:408547. [Accessed: 02 December 2022]

Please login to the repository to save this object to your list.